Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem’s manufacturing plant is located in Gujarat – INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
Objects of the Issue with Infinium Pharmachem IPO
The proceeds from the fresh issue will be utilized for the following objects:
1. Marketing and branding expenses (including registration in reach – Europe, and other marketing expenses).
2. Repayment of some of the existing loans and expansion of units.
3. To meet incremental working capital requirements.
4. To meet public issue expenses.
Financials of Infinium Pharmachem Limited
(Amount in ₹ Crore)
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|---|
| 31-Mar-20 | 2,244.60 | 3,941.64 | 93.40 | 424.74 | 566.17 |
| 31-Mar-21 | 3,418.27 | 7,115.37 | 272.48 | 702.32 | 579.47 |
| 31-Mar-22 | 5,899.95 | 10,005.25 | 610.64 | 1,310.22 | 1,385.01 |
| 30-Sep-22 | 7,075.71 | 7,985.39 | 551.01 | 1,855.77 | 1,614.71 |
Infinium Pharmachem IPO Details
| IPO Date | Mar 31, 2023 to Apr 5, 2023 |
| Listing Date | Apr 17, 2023 |
| Face Value | ₹10 per share |
| Price | ₹135 per share |
| Lot Size | 1000 Shares |
| Total Issue Size | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Fresh Issue | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Employee Discount | Rs 13.5 per share |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
Infinium Pharmachem IPO Tentative Timetable
Infinium Pharmachem IPO opens on Mar 31, 2023, and closes on Apr 5, 2023.
| Event | Tentative Date |
|---|---|
| Opening Date | Mar 31, 2023 |
| Closing Date | Apr 5, 2023 |
| Basis of Allotment | Apr 11, 2023 |
| Initiation of Refunds | Apr 12, 2023 |
| Credit of Shares to Demat | Apr 13, 2023 |
| Listing Date | Apr 17, 2023 |
| UPI Mandate Confirmation Cut-Off Time | 5.00 PM on the issue closing day |
Infinium Pharmachem IPO Lot Size
The Infinium Pharmachem IPO lot size is 1000 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1000 | ₹135,000 |
| Retail (Max) | 1 | 1000 | ₹135,000 |
| HNI (Min) | 2 | 2,000 | ₹270,000 |
Infinium Pharmachem IPO FAQs
What is Infinium Pharmachem IPO?
Infinium Pharmachem IPO is a SME IPO of 1,875,000 equity shares of the face value of ₹10 aggregating up to ₹25.26 Crores. The issue is priced at ₹135 per share. The minimum order quantity is 1000 Shares.
The IPO opens on Mar 31, 2023, and closes on Apr 5, 2023.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
When Infinium Pharmachem IPO will open?
The Infinium Pharmachem IPO opens on Mar 31, 2023 and closes on Apr 5, 2023.
What is the lot size of Infinium Pharmachem IPO?
Infinium Pharmachem IPO lot size is 1000 Shares.
How to apply for Infinium Pharmachem IPO?
You can apply in Infinium Pharmachem IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services.
When is Infinium Pharmachem IPO allotment?
The finalization of Basis of Allotment for Infinium Pharmachem IPO will be done on Apr 11, 2023, and the allotted shares will be credited to your demat account by Apr 13, 2023.
When is Infinium Pharmachem IPO listing date?
The date of Infinium Pharmachem IPO listing is Apr 17, 2023.